In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Russell 2000 With Bullish Breadth Divergences Our expectations since late September remain unchanged; equities are not yet out of the woods, but as long as the S&P 500 is above 4165-4200 and the 200-day MA, we are bullish, as most signs point to this being a normal pullback within the ongoing bullish trend in SPX. As discussed in last week's Compass (10/11/23), we have growing confidence that the lows are likely in on the SPX, which made a low at 4216 (with 4200 hit exactly overnight 10/4/23). ...
CMPR, TNET, ICFI, BCO, GRBK, DHI, SKX, RCL, ABC, HWKN, NVT, VSH, HLIT, AREWS, FOR, BWB, WTBA, CARE, COLB, HWC, NWBI, THC, LFST, HAE, VKTX, STRL, IESC, PRIM, PAA, USLM, CCF, PLPC, AMWD, WSO, HI, PNR, CXT, OII, PKOH, WMS, CA In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term ...
Rating Action: Moody's affirms AmerisourceBergen's Baa2 senior unsecured rating, outlook remains stable. Global Credit Research- 15 Mar 2022. New York, March 15, 2022-- Moody's Investors Service affirmed AmerisourceBergen Corporation's senior unsecured rating at Baa2 and its commercial paper rating at P-2.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of AmerisourceBergen Corporation. Global Credit Research- 26 Jan 2022. New York, January 26, 2022-- Moody's Investors Service has completed a periodic review of the ratings of AmerisourceBergen Corporation and other ratings that are associated with the same analytical unit.
AMERISOURCEBERGEN (US), a company active in the Drug Retailers industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 4 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date January 11, 2022, the closing price ...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Announcement: Moody's: Proposed opioids settlement is credit negative for AmerisourceBergen. Global Credit Research- 23 Jul 2021. New York, July 23, 2021-- Moody's Investors Service commented that the comprehensive opioids settlement proposal between the three largest drug distributors and the states and their political subdivisions is credit negative for AmerisourceBergen.
Rating Action: Moody's rates AmerisourceBergen's new unsecured notes at Baa2. Global Credit Research- 25 Mar 2021. New York, March 25, 2021-- Moody's Investors Service assigned a Baa2 rating to AmerisourceBergen Corporation's new senior unsecured notes.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of AmerisourceBergen Corporation. Global Credit Research- 01 Mar 2021. New York, March 01, 2021-- Moody's Investors Service has completed a periodic review of the ratings of AmerisourceBergen Corporation and other ratings that are associated with the same analytical unit.
Announcement: Moody's says Walgreens' sale of Alliance Healthcare has no immediate impact on ratings. Global Credit Research- 08 Jan 2021. New York, January 08, 2021-- Moody's Investors Service, says Walgreens Boots Alliance, Inc.' s sale of the majority of its Alliance Healthcare wholesale business to AmerisourceBergen Corporation for gross proceeds of about $6.5 billion consisting of $6.275 billion in cash and about $200 million in Amerisource Bergen common stock has no...
Rating Action: Moody's affirms AmerisourceBergen's Baa2 senior unsecured rating; outlook stable. Global Credit Research- 06 Jan 2021. New York, January 06, 2021-- Moody's Investors Service affirmed the Baa2 senior unsecured ratings of AmerisourceBergen Corporation following its announcement that it will acquire Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion.
Summary Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Allergan plc (Allergan or 'the company') is a pharmaceutical company that develops, manufactures and markets branded pharmaceutical products, biologic, device, surgical and regenerative medicine ...
Rating Action: Moody's rates AmerisourceBergen's new senior unsecured bonds at Baa2. Global Credit Research- 12 May 2020. New York, May 12, 2020-- Moody's Investors Service assigned a Baa2 rating to AmerisourceBergen Corporation's new senior unsecured bonds.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of AmerisourceBergen Corporation. Global Credit Research- 06 Apr 2020. New York, April 06, 2020-- Moody's Investors Service has completed a periodic review of the ratings of AmerisourceBergen Corporation and other ratings that are associated with the same analytical unit.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.